87 related articles for article (PubMed ID: 16158948)
1. Paracrine calcitonin in prostate cancer is linked to CD44 variant expression and invasion.
Iczkowski KA; Omara-Opyene AL; Kulkarni TR; Pansara M; Shah GV
Anticancer Res; 2005; 25(3B):2075-83. PubMed ID: 16158948
[TBL] [Abstract][Full Text] [Related]
2. Role of stimulatory guanine nucleotide binding protein (GSalpha) in proliferation of PC-3M prostate cancer cells.
Chien J; Shah GV
Int J Cancer; 2001 Jan; 91(1):46-54. PubMed ID: 11149419
[TBL] [Abstract][Full Text] [Related]
3. The predominant CD44 splice variant in prostate cancer binds fibronectin, and calcitonin stimulates its expression.
Iczkowski KA; Omara-Opyene AL; Shah GV
Anticancer Res; 2006; 26(4B):2863-72. PubMed ID: 16886606
[TBL] [Abstract][Full Text] [Related]
4. Prostate cancer overexpresses CD44 variants 7-9 at the messenger RNA and protein level.
Iczkowski KA; Bai S; Pantazis CG
Anticancer Res; 2003; 23(4):3129-40. PubMed ID: 12926045
[TBL] [Abstract][Full Text] [Related]
5. MAP kinase pathways and calcitonin influence CD44 alternate isoform expression in prostate cancer cells.
Robbins EW; Travanty EA; Yang K; Iczkowski KA
BMC Cancer; 2008 Sep; 8():260. PubMed ID: 18793421
[TBL] [Abstract][Full Text] [Related]
6. Constitutive activation of stimulatory guanine nucleotide binding protein (G(S)alphaQL)-mediated signaling increases invasiveness and tumorigenicity of PC-3M prostate cancer cells.
Chien J; Wong E; Nikes E; Noble MJ; Pantazis CG; Shah GV
Oncogene; 1999 Jun; 18(22):3376-82. PubMed ID: 10362358
[TBL] [Abstract][Full Text] [Related]
7. Calcitonin increases invasiveness of prostate cancer cells: role for cyclic AMP-dependent protein kinase A in calcitonin action.
Sabbisetti VS; Chirugupati S; Thomas S; Vaidya KS; Reardon D; Chiriva-Internati M; Iczkowski KA; Shah GV
Int J Cancer; 2005 Nov; 117(4):551-60. PubMed ID: 15929083
[TBL] [Abstract][Full Text] [Related]
8. The influence of CD44v3-v10 on adhesion, invasion and MMP-14 expression in prostate cancer cells.
Harrison GM; Davies G; Martin TA; Mason MD; Jiang WG
Oncol Rep; 2006 Jan; 15(1):199-206. PubMed ID: 16328056
[TBL] [Abstract][Full Text] [Related]
9. Calcitonin is a prostate epithelium-derived growth stimulatory peptide.
Chien J; Ren Y; Qing Wang Y; Bordelon W; Thompson E; Davis R; Rayford W; Shah G
Mol Cell Endocrinol; 2001 Jul; 181(1-2):69-79. PubMed ID: 11476942
[TBL] [Abstract][Full Text] [Related]
10. Calcitonin increases tumorigenicity of prostate cancer cells: evidence for the role of protein kinase A and urokinase-type plasminogen receptor.
Thomas S; Chigurupati S; Anbalagan M; Shah G
Mol Endocrinol; 2006 Aug; 20(8):1894-911. PubMed ID: 16574742
[TBL] [Abstract][Full Text] [Related]
11. Interleukin 8 expression regulates tumorigenicity and metastases in androgen-independent prostate cancer.
Inoue K; Slaton JW; Eve BY; Kim SJ; Perrotte P; Balbay MD; Yano S; Bar-Eli M; Radinsky R; Pettaway CA; Dinney CP
Clin Cancer Res; 2000 May; 6(5):2104-19. PubMed ID: 10815938
[TBL] [Abstract][Full Text] [Related]
12. Calcitonin receptor-stimulated migration of prostate cancer cells is mediated by urokinase receptor-integrin signaling.
Thomas S; Chiriva-Internati M; Shah GV
Clin Exp Metastasis; 2007; 24(5):363-77. PubMed ID: 17487556
[TBL] [Abstract][Full Text] [Related]
13. Calcitonin promotes in vivo metastasis of prostate cancer cells by altering cell signaling, adhesion, and inflammatory pathways.
Shah GV; Thomas S; Muralidharan A; Liu Y; Hermonat PL; Williams J; Chaudhary J
Endocr Relat Cancer; 2008 Dec; 15(4):953-64. PubMed ID: 18784182
[TBL] [Abstract][Full Text] [Related]
14. Stress-response protein RBM3 attenuates the stem-like properties of prostate cancer cells by interfering with CD44 variant splicing.
Zeng Y; Wodzenski D; Gao D; Shiraishi T; Terada N; Li Y; Vander Griend DJ; Luo J; Kong C; Getzenberg RH; Kulkarni P
Cancer Res; 2013 Jul; 73(13):4123-33. PubMed ID: 23667174
[TBL] [Abstract][Full Text] [Related]
15. Calcitonin induces stem cell-like phenotype in prostate cancer cells.
Aldahish A; Kale A; Aljameeli A; Shah GV
Endocr Relat Cancer; 2019 Nov; 26(11):815-828. PubMed ID: 31561211
[TBL] [Abstract][Full Text] [Related]
16. A-kinase anchoring protein 2 is required for calcitonin-mediated invasion of cancer cells.
Thakkar A; Aljameeli A; Thomas S; Shah GV
Endocr Relat Cancer; 2016 Jan; 23(1):1-14. PubMed ID: 26432469
[TBL] [Abstract][Full Text] [Related]
17. Prostate cancer invasion is influenced more by expression of a CD44 isoform including variant 9 than by Muc18.
Omara-Opyene AL; Qiu J; Shah GV; Iczkowski KA
Lab Invest; 2004 Jul; 84(7):894-907. PubMed ID: 15107804
[TBL] [Abstract][Full Text] [Related]
18. CD44 variant 6 is associated with prostate cancer metastasis and chemo-/radioresistance.
Ni J; Cozzi PJ; Hao JL; Beretov J; Chang L; Duan W; Shigdar S; Delprado WJ; Graham PH; Bucci J; Kearsley JH; Li Y
Prostate; 2014 May; 74(6):602-17. PubMed ID: 24615685
[TBL] [Abstract][Full Text] [Related]
19. Differential expression of the hyaluronan receptors CD44 and RHAMM in human pancreatic cancer cells.
Abetamann V; Kern HF; Elsässer HP
Clin Cancer Res; 1996 Sep; 2(9):1607-18. PubMed ID: 9816340
[TBL] [Abstract][Full Text] [Related]
20. Calcitonin inhibits invasion of breast cancer cells: involvement of urokinase-type plasminogen activator (uPA) and uPA receptor.
Han B; Nakamura M; Zhou G; Ishii A; Nakamura A; Bai Y; Mori I; Kakudo K
Int J Oncol; 2006 Apr; 28(4):807-14. PubMed ID: 16525628
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
